| Literature DB >> 33484409 |
David J Tomlinson1, Robert M Erskine2,3, Christopher I Morse4, Joseph M Pappachan5, Emmanuel Sanderson-Gillard4, Gladys L Onambélé-Pearson4.
Abstract
PURPOSE: We investigated the combined impact of ageing and obesity on Achilles tendon (AT) properties in vivo in men, utilizing three classification methods of obesity.Entities:
Keywords: Adiposity; Aging; Body fat percentage; Body mass index; Obesity; Tendon
Year: 2021 PMID: 33484409 PMCID: PMC8128745 DOI: 10.1007/s12020-020-02601-0
Source DB: PubMed Journal: Endocrine ISSN: 1355-008X Impact factor: 3.633
Fig. 1A collage of ultrasound outputs at three points of tendon elongation (I = 10%, ii = 50% and iii = 100% of tendon displacement under isometric loading); vertical red line indicates microfilm tape reference marker, while the two converging red lines display the muscle–tendon junction of the gastrocnemius medialis
Descriptive participant characteristics and physical activity scores grouped by age and three measurements of obesity
Participant characteristics values are means ± SDs. Physical activity score values are median (interquartile range). Bold denotes significant group differences and labelled ‘a,b, c’ body mass index, and fat mass index means in a row without a common letter differ, P < 0.05. Grey shading denote non-parametric Kruskal–Wallis (body mass index and fat mass index) and Mann–Whitney (age, body fat% and pairwise comparisons) tests
BMI body mass index, FMI fat mass index
Ankle joint range of motion, rate of torque development (RTD) and gastrocnemius medialis (GM)/Achilles tendon (AT) properties grouped by age and three classifications of obesity
Values are means ± SDs. Bold denotes significant group differences and labelled ‘a and b’ body mass index, and fat mass index means in a row without a common letter differ, P < 0.05. Grey shading denote non-parametric Kruskal–Wallis (body mass index and fat mass index and Mann–Whitney (age, body fat% and pairwise comparisons) tests
CSA cross sectional area, HA high adipose, NA normal adipose, NW normal weight, Ob obese, Ov overweight, ROM range of motion
Fig. 2Group mean (±SD) Gastrocnemius Medialis tendon force-elongation plots categorised by A age, B body mass index, C body fat% and D fat mass index. Values are calculated at 10% increments of participants’ maximum voluntary contraction. Significant main effects are highlighted by *P < 0.05
Bivariate correlations between measures of body composition and gastrocnemius medialis (GM)/Achilles tendon (AT) properties in young and old adult men
| Young | Old | |||||||
|---|---|---|---|---|---|---|---|---|
| Body mass | BMI | Body fat% | FMI | Body mass | BMI | Body fat% | FMI | |
| AT CSA | 0.644** | 0.541* | 0.382¥ | 0.244 | ||||
| GM force | 0.342 | 0.203 | 0.003 | 0.138 | ||||
| GM tendon stiffness | 0.520* | 0.493* | 0.236 | 0.245 | ||||
| Standardised GM tendon stiffness | 0.332 | 0.236 | 0.165 | |||||
| Young’s modulus | 0.120 | 0.131 | −0.040 | |||||
| Standardised Young’s modulus | 0.037 | −0.017 | 0.002 | |||||
| AT stress | −0.397¥ | −0.413¥ | −0.353 | −0.048 | ||||
| GM tendon strain | −0.380¥ | −0.400¥ | −0.264 | −0.283 | ||||
Data shown are correlation coefficients. Significant correlations are highlighted by *P < 0.05; **P < 0.01; trends P < 0.1 are highlighted by ¥. Spearman correlations are given in bold
BMI body mass index, FMI fat mass index
Bivariate Spearman correlation coefficients between Achilles tendon (AT) characteristics and 11 inflammatory cytokines and chemokines
| AT CSA | Tendon stiffness | Tendon stiffness (standardised) | Young’s modulus | Young’s modulus (standardised) | Stress | Strain | |
|---|---|---|---|---|---|---|---|
| Pro-inflammatory | |||||||
| IL-1β | −0.630** | 0.134 | −0.017 | 0.374 | 0.108 | 0.309 | −0.165 |
| IL-6 | −0.507* | 0.152 | 0.060 | 0.418 | 0.167 | 0.361 | −0.115 |
| TNF-α | −0.544* | 0.064 | −0.035 | 0.329 | 0.091 | 0.307 | 0.006 |
| G-CSF | 0.080 | 0.564* | 0.116 | 0.381 | 0.111 | 0.399 | −0.301 |
| IFN-γ | −0.042 | 0.424 | −0.065 | 0.316 | −0.088 | 0.255 | −0.249 |
| Anti-inflammatory | |||||||
| IL-10 | −0.681** | 0.064 | 0.120 | 0.423 | 0.296 | 0.365 | −0.186 |
| TGF-β1 | 0.491¥ | 0.434¥ | 0.162 | 0.068 | 0.000 | 0.047 | −0.221 |
| TGF-β2 | 0.381 | 0.146 | −0.070 | −0.043 | −0.196 | −0.227 | −0.16 |
| TGF-β3 | 0.374 | −0.106 | −0.346 | −0.155 | −0.367 | −0.326 | 0.038 |
| Chemokine | |||||||
| IL-8 | −0.280 | 0.196 | −0.017 | 0.384 | 0.032 | 0.264 | −0.239 |
| MCP-1 | 0.035 | 0.420 | 0.073 | 0.218 | −0.053 | 0.109 | −0.378 |
| MIP-1α | −0.132 | 0.503* | 0.032 | 0.396 | 0.096 | 0.494¥ | −0.159 |
| MIP-1β | 0.185 | 0.710** | 0.503* | 0.562* | 0.350 | 0.435¥ | −0.624** |
| RANTES | 0.732** | 0.402 | 0.296 | 0.097 | 0.107 | 0.097 | −0.188 |
Significance: *P < 0.05, **P < 0.01, trends ¥P < 0.01
IFN interferon gamma, IL interleukin, G-CSF granulocyte-colony-stimulating factor, MCP-1 monocyte chemoattractant protein 1, MIP macrophage inflammatory protein, RANTES regulated on activation, normal T-cell expressed and secreted, TGF transforming growth factor, TNF tumour necrosis factor